A major earthquake striking Cambridge, Massachusetts.
LOL And I pretty much agree. There are clearly several big ways to win with MNTA and if even just one of these pans out over the intermediate term, I think us current longs will be quite pleased. I.e., even if TEVA manages to gain approval for tEnox, we still have the prospect of generic Copaxone, the FoB platform, the cancer drug, and M118. This is why I view any TEVA approval of tEnox and subsequent plunge in MNTA share price as a nice buying opportunity (and why I hope to have some powder dry should such an opportunity ever come to pass).
News 
Market Data 
Discover 
AI
